𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic influences on cognitive decline in Parkinson's disease

✍ Scribed by James F. Morley; Sharon X. Xie; Howard I. Hurtig; Matthew B. Stern; Amy Colcher; Stacy Horn; Nabila Dahodwala; John E. Duda; Daniel Weintraub; Alice S. Chen-Plotkin; Vivianna Van Deerlin; Dana Falcone; Andrew Siderowf

Book ID
102947092
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
839 KB
Volume
27
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The role of genetic factors in cognitive decline associated with Parkinson's disease (PD) is unclear. We examined whether variations in apolipoprotein E (APOE), microtubule‐associated protein tau (MAPT), or catechol‐O‐methytransferase (COMT) genotypes are associated with cognitive decline in PD. We performed a prospective cohort study of 212 patients with a clinical diagnosis of PD. The primary outcome was change in Mattis Dementia Rating Scale version 2 score. Linear mixed‐effects models and survival analysis were used to test for associations between genotypes and change in cognitive function over time. The ε4 allele of APOE was associated with more rapid decline (loss of 2.9; 95% confidence interval [CI]: 1.7–4.1) of more points per year; P < 0.001) in total score and an increased risk of a ≥10 point drop during the follow‐up period (hazard ratio, 2.8; 95% CI: 1.4–5.4; P = 0.003). MAPT haplotype and COMT genotype were associated with measures of memory and attention, respectively, over the entire follow‐up period, but not with the overall rate of cognitive decline. These results confirm and extend previously described genetic associations with cognitive decline in PD and imply that individual genes may exert effects on specific cognitive domains or at different disease stages. Carrying at least one APOE ε4 allele is associated with more rapid cognitive decline in PD, supporting the idea of a component of shared etiology between PD dementia and Alzheimer's disease. Clinically, these results suggest that genotyping can provide information about the risk of future cognitive decline for PD patients. © 2012 Movement Disorder Society

📜 SIMILAR VOLUMES

Cognitive decline in early Parkinson's d
Cognitive decline in early Parkinson's disease
✍ Nagaendran Kandiah; Kaavya Narasimhalu; Puay-Ngoh Lau; Soo-Hoon Seah; Wing Lok A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

## Abstract Data on the prevalence and severity of cognitive impairment among patients with newly diagnosed idiopathic Parkinson's disease (PD) is limited. Using a prospectively collected clinical database, we studied the longitudinal trend of mini‐mental state examination (MMSE) change and baselin

Orthostatic hypotension in Parkinson's d
Orthostatic hypotension in Parkinson's disease: association with cognitive decline?
✍ Liesl M. Allcock; Rose Anne Kenny; Urs Peter Mosimann; Sherley Tordoff; Keith A. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

## Abstract ## Background Orthostatic hypotension is common in Lewy body disorders and may be related to disease progression and the spread of Lewy body pathology. We therefore hypothesize that PD patients with orthostatic hypotension (OH) have a different cognitive profile compared to PD patients

Apathy may herald cognitive decline and
Apathy may herald cognitive decline and dementia in Parkinson's disease
✍ Kathy Dujardin; Pascal Sockeel; Marie Delliaux; Alain Destée; Luc Defebvre 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Abstract Apathy is usually defined as a lack of motivation. It may occur as part of another disorder (notably depression and dementia) or as an isolated syndrome. In Parkinson's disease (PD), apathy is common and several studies have reported an association between this condition and more severe